The following table sets forth the computation of basic and diluted loss per share (“EPS”) for the periods indicated.


	Three Months Ended June 30,						Six Months Ended June 30,
	2022			2021			2022			2021
Basic loss per share:
Net loss attributable to common stockholders (000's)	$	(87,866	)	$	(3,950	)	$	(118,625	)	$	(9,097	)
Weighted average shares outstanding		26,453,456			27,904,923			26,620,418			27,866,364
Basic loss per share:	$	(3.32	)	$	(0.14	)	$	(4.46	)	$	(0.33	)

Diluted loss per share:
Net loss attributable to common stockholders (000's)	$	(87,866	)	$	(3,950	)	$	(118,625	)	$	(9,097	)
Weighted average shares outstanding		26,453,456			27,904,923			26,620,418			27,866,364
Total weighted average dilutive shares		26,453,456			27,904,923			26,620,418			27,866,364
Diluted loss per share:	$	(3.32	)	$	(0.14	)	$	(4.46	)	$	(0.33	)

The Company had 2,370,531 and 2,452,412 antidilutive shares for the six-month period ended June 30, 2022 and 2021, respectively. The convertible notes were excluded from the computations because the conversion price on these notes was greater than the average market price of our common shares during each of the respective periods, and therefore, would be anti-dilutive to earnings per share under the "if converted" method under the guidance of ASU 2020-06, adopted by the Company on January 1, 2022.